- Home
- EVC vs FENC Comparison
EVC vs FENC Comparison
Compare EVC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- FENC
- Stock Information
- Founded
- EVC 1996
- FENC 1996
- Country
- EVC United States
- FENC United States
- Employees
- EVC N/A
- FENC N/A
- Industry
- EVC Broadcasting
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVC Industrials
- FENC Health Care
- Exchange
- EVC Nasdaq
- FENC Nasdaq
- Market Cap
- EVC 171.0M
- FENC 156.9M
- IPO Year
- EVC 2000
- FENC 2001
- Fundamental
- Price
- EVC $2.07
- FENC $8.12
- Analyst Decision
- EVC
- FENC Strong Buy
- Analyst Count
- EVC 0
- FENC 2
- Target Price
- EVC N/A
- FENC $13.00
- AVG Volume (30 Days)
- EVC 185.0K
- FENC 105.2K
- Earning Date
- EVC 05-08-2025
- FENC 05-13-2025
- Dividend Yield
- EVC 9.66%
- FENC N/A
- EPS Growth
- EVC N/A
- FENC N/A
- EPS
- EVC N/A
- FENC N/A
- Revenue
- EVC $378,623,000.00
- FENC $30,912,000.00
- Revenue This Year
- EVC $64.06
- FENC N/A
- Revenue Next Year
- EVC N/A
- FENC $58.65
- P/E Ratio
- EVC N/A
- FENC N/A
- Revenue Growth
- EVC 23.10
- FENC N/A
- 52 Week Low
- EVC $1.58
- FENC $3.96
- 52 Week High
- EVC $2.73
- FENC $8.56
- Technical
- Relative Strength Index (RSI)
- EVC 62.90
- FENC 71.48
- Support Level
- EVC $1.85
- FENC $7.56
- Resistance Level
- EVC $2.04
- FENC $8.34
- Average True Range (ATR)
- EVC 0.08
- FENC 0.47
- MACD
- EVC 0.02
- FENC 0.10
- Stochastic Oscillator
- EVC 86.67
- FENC 83.27
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.